Man­u­fac­tur­ing roundup: Lon­za col­lab­o­rates with a VC in Is­rael; Pi­ra­mal up­dates one fa­cil­i­ty while open­ing a new one

The Swiss CD­MO pow­er­house Lon­za is no stranger to Is­rael, but a re­cent col­lab­o­ra­tion has ce­ment­ed a new hold over biotech in the re­gion.

Ac­cord­ing to the com­pa­ny, Lon­za and the Is­rael Biotech Fund, a ven­ture fund in­vest­ing in Is­raeli and Is­raeli-re­lat­ed biotech com­pa­nies, an­nounced a two-year frame­work agree­ment.

The deal aims to pro­vide ac­cel­er­at­ed time­lines for the de­vel­op­ment and man­u­fac­ture of bi­o­log­ics and small mol­e­cules. Lon­za will add sup­port to the IBF by work­ing to de-risk and pro­vide de­vel­op­ment and man­u­fac­tur­ing ser­vices to the IBF’s port­fo­lio com­pa­nies. The fi­nan­cial terms of the deal were not dis­closed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER